FDA Approves Medtronic’s CRT Devices For Less Severe Heart Failure
This article was originally published in The Gray Sheet
Executive Summary
Following the advice of its advisory panel, FDA expanded the indication for two Medtronic cardiac resynchronization pacemakers and eight cardiac resynchronization defibrillators to include patients with atrioventricular block and less severe heart failure.